-
Je něco špatně v tomto záznamu ?
In vitro effects of the citrus flavonoids diosmin, naringenin and naringin on the hepatic drug-metabolizing CYP3A enzyme in human, pig, mouse and fish
V. Burkina, V. Zlabek, R. Halsne, E. Ropstad, G. Zamaratskaia,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- Citrus chemie MeSH
- cytochrom P-450 CYP3A genetika metabolismus MeSH
- diosmin farmakologie MeSH
- druhová specificita MeSH
- exprese genu MeSH
- flavanony farmakologie MeSH
- hydrolýza MeSH
- inhibitory enzymů farmakologie MeSH
- jaterní mikrozomy účinky léků enzymologie MeSH
- játra účinky léků enzymologie MeSH
- kinetika MeSH
- kumariny metabolismus MeSH
- lidé MeSH
- myši inbrední ICR MeSH
- myši MeSH
- Oncorhynchus mykiss MeSH
- prasata MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Flavonoids are known to have effects on cytochrome P450 enzymatic activity. However, little effort has been made to examine species differences and the relevance of studies on mammalian and fish microsomes so that extrapolations can be made to humans. Therefore, the effects of several naturally occurring flavonoids on the activity of CYP3A-dependent 7-benzyloxy-4-trifluoromethylcoumarin O-debenzylase (BFCOD) were evaluated in human, pig, mouse, and juvenile rainbow trout sources of hepatic microsomes. Each was exposed to three concentrations (1, 10, and 100μM) of diosmin, naringin, and naringenin. Naringenin competitively inhibited BFCOD activity (Ki values were 24.6μM in human, 15.6μM in pig, and 19.6μM in mouse microsomes). In fish, BFCOD activity was inhibited in a noncompetitive manner (Ki=7μM). Neither diosmin nor naringenin affected BFCOD activity in hepatic microsomes from the studied model organisms. These results suggest that dietary flavonoids potentially inhibit the metabolism of clinical drugs.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17024045
- 003
- CZ-PrNML
- 005
- 20170720123628.0
- 007
- ta
- 008
- 170720s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bcp.2016.04.011 $2 doi
- 035 __
- $a (PubMed)27107807
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Burkina, Viktoriia $u University of South Bohemia in Ceske Budejovice, Faculty of Fisheries and Protection of Waters, South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Zatisi 728/II, 389 25 Vodnany, Czech Republic. Electronic address: vburkina@frov.jcu.cz.
- 245 10
- $a In vitro effects of the citrus flavonoids diosmin, naringenin and naringin on the hepatic drug-metabolizing CYP3A enzyme in human, pig, mouse and fish / $c V. Burkina, V. Zlabek, R. Halsne, E. Ropstad, G. Zamaratskaia,
- 520 9_
- $a Flavonoids are known to have effects on cytochrome P450 enzymatic activity. However, little effort has been made to examine species differences and the relevance of studies on mammalian and fish microsomes so that extrapolations can be made to humans. Therefore, the effects of several naturally occurring flavonoids on the activity of CYP3A-dependent 7-benzyloxy-4-trifluoromethylcoumarin O-debenzylase (BFCOD) were evaluated in human, pig, mouse, and juvenile rainbow trout sources of hepatic microsomes. Each was exposed to three concentrations (1, 10, and 100μM) of diosmin, naringin, and naringenin. Naringenin competitively inhibited BFCOD activity (Ki values were 24.6μM in human, 15.6μM in pig, and 19.6μM in mouse microsomes). In fish, BFCOD activity was inhibited in a noncompetitive manner (Ki=7μM). Neither diosmin nor naringenin affected BFCOD activity in hepatic microsomes from the studied model organisms. These results suggest that dietary flavonoids potentially inhibit the metabolism of clinical drugs.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a Citrus $x chemie $7 D002957
- 650 _2
- $a kumariny $x metabolismus $7 D003374
- 650 _2
- $a cytochrom P-450 CYP3A $x genetika $x metabolismus $7 D051544
- 650 _2
- $a diosmin $x farmakologie $7 D004145
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a flavanony $x farmakologie $7 D044950
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydrolýza $7 D006868
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a játra $x účinky léků $x enzymologie $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední ICR $7 D008813
- 650 _2
- $a jaterní mikrozomy $x účinky léků $x enzymologie $7 D008862
- 650 _2
- $a Oncorhynchus mykiss $7 D017686
- 650 _2
- $a druhová specificita $7 D013045
- 650 _2
- $a prasata $7 D013552
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zlabek, Vladimir $u University of South Bohemia in Ceske Budejovice, Faculty of Fisheries and Protection of Waters, South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Zatisi 728/II, 389 25 Vodnany, Czech Republic. Electronic address: vzlabek@frov.jcu.cz.
- 700 1_
- $a Halsne, Ruth $u Norwegian University of Life Sciences, Faculty of Veterinary Medicine and Biosciences, Department of Production Animal Clinical Sciences, P.O. 8146 Dep., N-0033 Oslo, Norway. Electronic address: ruth.halsne@nmbu.no.
- 700 1_
- $a Ropstad, Erik $u Norwegian University of Life Sciences, Faculty of Veterinary Medicine and Biosciences, Department of Production Animal Clinical Sciences, P.O. 8146 Dep., N-0033 Oslo, Norway. Electronic address: erik.ropstad@nmbu.no.
- 700 1_
- $a Zamaratskaia, Galia $u University of South Bohemia in Ceske Budejovice, Faculty of Fisheries and Protection of Waters, South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Zatisi 728/II, 389 25 Vodnany, Czech Republic; Swedish University of Agricultural Sciences, Uppsala BioCenter, Department of Food Science, P.O. Box 7051, SE-750 07 Uppsala, Sweden. Electronic address: Galia.Zamaratskaia@slu.se.
- 773 0_
- $w MED00000704 $t Biochemical pharmacology $x 1873-2968 $g Roč. 110-111, č. - (2016), s. 109-16
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27107807 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170720124121 $b ABA008
- 999 __
- $a ok $b bmc $g 1239726 $s 984958
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 110-111 $c - $d 109-16 $e 20160420 $i 1873-2968 $m Biochemical pharmacology $n Biochem Pharmacol $x MED00000704
- LZP __
- $a Pubmed-20170720